Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

References

• Wang C-Y, Babitt JL. Liver iron sensing and body iron homeostasis. Blood. 2019;133:18–29.
   PubMed Web of Science ®Google Scholar
• Gerhard GS, Paynton BV, DiStefano JK. Identification of genes for hereditary hemochromatosis. Methods Mol Biol. 2018;1706:353–365.
   Google Scholar
• Brissot P, Pietrangelo A, Adams PC, et al. Haemochromatosis. Nat Rev Dis Primers. 2018;4(1):18016. doi:10.1038/nrdp.2018.16
   Web of Science ®Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–7810. doi:10.1074/jbc.M008922200
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106(Supplement 6):1559S–1566S. doi:10.3945/ajcn.117.155804
   PubMed Web of Science ®Google Scholar
• Kowdley KV, Gochanour EM, Sundaram V, Shah RA, Handa P. Hepcidin signaling in health and disease: ironing out the details. Hepatol Commun. 2021;5(5):723–735. doi:10.1002/hep4.1717
   Web of Science ®Google Scholar
• Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther. 2012;35(8):876–893. doi:10.1111/j.1365-2036.2012.05051.x
   PubMed Web of Science ®Google Scholar
• Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108(4):619–623. doi:10.1172/JCI200113468
   Web of Science ®Google Scholar
• Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352(17):1769–1778. doi:10.1056/NEJMoa041534
   PubMed Web of Science ®Google Scholar
• Gochee PA, Powell LW. What’s new in hemochromatosis. Curr Opin Hematol. 2001;8(2):98–104. doi:10.1097/00062752-200103000-00007
   Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408. doi:10.1038/ng0896-399
   PubMed Web of Science ®Google Scholar
• Zaloumis SG, Allen KJ, Bertalli NA, et al. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study. J Gastroenterol Hepatol. 2015;30(4):719–725. doi:10.1111/jgh.12804
   PubMed Web of Science ®Google Scholar
• Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114(8):1202–1218. doi:10.14309/ajg.0000000000000315
   Web of Science ®Google Scholar
• European Association For The Study Of The Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010;53:3–22.
   Web of Science ®Google Scholar
• Arts HH, Eng B, Waye JS. Multiplex allele-specific PCR for simultaneous detection of H63D and C282Y HFE mutations in hereditary hemochromatosis. J Appl Lab Med. 2018;3(1):10–17. doi:10.1373/jalm.2017.024984
   Google Scholar
• Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis. Nat Genet. 2004;36(1):77–82. doi:10.1038/ng1274
   PubMed Web of Science ®Google Scholar
• Camaschella C, Roetto A, Calì A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25(1):14–15. doi:10.1038/75534
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis. 2004;32(1):131–138. doi:10.1016/j.bcmd.2003.08.003
   PubMed Web of Science ®Google Scholar
• Sandhu K, Flintoff K, Chatfield MD, et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood. 2018 Jul 5;132(1):101–110. doi:10.1182/blood-2018-02-830562
   Web of Science ®Google Scholar
• Kato J, Fujikawa K, Kanda M, et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69(1):191–197. doi:10.1086/321261
   Web of Science ®Google Scholar
• Roberti MDRF, Borges Filho HM, Gonçalves CH, Lima FL. Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases. Rev Bras Hematol Hemoter. 2011;33(5):389–392. doi:10.5581/1516-8484.20110104
   PubMedGoogle Scholar
• Mayr R, Janecke AR, Schranz M, et al. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol. 2010;53(5):941–949. doi:10.1016/j.jhep.2010.05.016
   Web of Science ®Google Scholar
• Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(S3):228–237. doi:10.1038/ng1090
   Web of Science ®Google Scholar
• Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988;42:677–693.
   PubMed Web of Science ®Google Scholar
• Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science. 1987;236(4808):1567–1570. doi:10.1126/science.2884728
   PubMed Web of Science ®Google Scholar
• Kerem B, Rommens J, Buchanan J, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245(4922):1073–1080. doi:10.1126/science.2570460
   PubMed Web of Science ®Google Scholar
• Claussnitzer M, Cho JH, Collins R, et al. A brief history of human disease genetics. Nature. 2020;577(7789):179–189. doi:10.1038/s41586-019-1879-7
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
   PubMed Web of Science ®Google Scholar
• Chong JX, Buckingham K, Jhangiani S, et al. The genetic basis of mendelian phenotypes: discoveries, challenges, and opportunities. Am J Hum Genet. 2015;97(2):199–215. doi:10.1016/j.ajhg.2015.06.009
   PubMed Web of Science ®Google Scholar
• Makrythanasis P, Antonarakis SE. Pathogenic variants in non-protein-coding sequences. Clin Genet. 2013;84(5):422–428. doi:10.1111/cge.12272
   PubMed Web of Science ®Google Scholar
• Stranneheim H, Wedell A. Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders. J Intern Med. 2016;279(1):3–15. doi:10.1111/joim.12399
   PubMed Web of Science ®Google Scholar
• Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018;20(10):1122–1130. doi:10.1038/gim.2017.247
   PubMed Web of Science ®Google Scholar
• Gilissen C, Hoischen A, Brunner HG, Veltman JA. Unlocking mendelian disease using exome sequencing. Genome Biol. 2011;12(9):228. doi:10.1186/gb-2011-12-9-228
   PubMed Web of Science ®Google Scholar
• Jelin AC, Vora N. Whole exome sequencing: applications in prenatal genetics. Obstet Gynecol Clin North Am. 2018;45(1):69–81. doi:10.1016/j.ogc.2017.10.003
   PubMed Web of Science ®Google Scholar
• Salfati EL, Spencer EG, Topol SE, et al. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases. Genome Med. 2019;11(1):83. doi:10.1186/s13073-019-0702-2
   Web of Science ®Google Scholar
• Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369(16):1502–1511. doi:10.1056/NEJMoa1306555
   PubMed Web of Science ®Google Scholar
• Chang Y-S, Lin C-Y, Huang H-Y, Chang J-G, Kuo H-T. Chromosomal microarray and whole-exome sequence analysis in Taiwanese patients with autism spectrum disorder. Mol Genet Genomic Med. 2019;7(12):e996. doi:10.1002/mgg3.996
   Web of Science ®Google Scholar
• Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–764. doi:10.1016/j.ajhg.2010.04.006
   PubMed Web of Science ®Google Scholar
• Franceschini N, Frick A, Kopp JB. Genetic testing in clinical settings. Am J Kidney Dis. 2018;72(4):569–581. doi:10.1053/j.ajkd.2018.02.351
   Web of Science ®Google Scholar
• Barton JC, Acton RT, Rivers CA, et al. Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis. 2003;31(3):310–319. doi:10.1016/S1079-9796(03)00166-9
   Web of Science ®Google Scholar
• Santos PCJL, Krieger JE, Pereira AC. Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int J Mol Sci. 2012;13(2):1497–1511. doi:10.3390/ijms13021497
   Web of Science ®Google Scholar
• Blueprint Genetics. Available from: https://blueprintgenetics.com/tests/panels/metabolic-disorders/hereditary-hemochromatosis-panel/. Accessed July 20, 2021.
   Google Scholar
• Fulgent Genetics. Available from: https://www.fulgentgenetics.com/products/disease/raredisease.html. Accessed July 20, 2021.
   Google Scholar
• Invitae. Available from: https://www.invitae.com/en/physician/tests/05201/. Accessed July 20, 2021.
   Google Scholar
• Prevention Genetics. Available from: https://www.preventiongenetics.com/testInfo?val=Hereditary+Hemochromatosis+Panel. Accessed July 20, 2021.
   Google Scholar
• Valencian Institute of Microbiology (Ivami). Available from: https://www.ivami.com/en/genetic-testing-human-gene-mutations-diseases-neoplasias-and-pharmacogenetics/4301-genetic-testing-hereditary-hemochromatosis-i-hamp-hfe-hfe2-slca40a1-i-and-i-tfr2-i. Accessed July 20, 2021.
   Google Scholar
• Baylor Genetics. Available from: https://baylorgenetics.com/. Accessed July 20, 2021.
   Google Scholar
• Pagani A, Silvestri L, Nai A, Camaschella C. Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response. Haematologica. 2008;93(10):1466–1472. doi:10.3324/haematol.12508
   Web of Science ®Google Scholar
• Li C-X, Zhang L, Wang P, Sun L. Clinicopathological diagnosis and treatment of juvenile hemochromatosis. Chin Med J. 2019;132(24):3018–3020. doi:10.1097/CM9.0000000000000547
   Web of Science ®Google Scholar
• Lee PL, Beutler E, Rao SV, Barton JC. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood. 2004;103(12):4669–4671. doi:10.1182/blood-2004-01-0072
   PubMed Web of Science ®Google Scholar
• Cherfane C, Lee P, Guerin L, Brown K. A late presentation of a fatal disease: juvenile hemochromatosis. Case Rep Med. 2013;2013:875093. doi:10.1155/2013/875093
   Google Scholar
• Filali M, Le Jeunne C, Durand E, et al. Juvenile hemochromatosis HJV-related revealed by cardiogenic shock. Blood Cells Mol Dis. 2004;33(2):120–124. doi:10.1016/j.bcmd.2004.05.001
   PubMed Web of Science ®Google Scholar
• Murugan RC, Lee PL, Kalavar MR, Barton JC. Early age-of-onset iron overload and homozygosity for the novel hemojuvelin mutation HJV R54X (exon 3; c.160A→T) in an African American male of West Indies descent. Clin Genet. 2008;74(1):88–92. doi:10.1111/j.1399-0004.2008.01017.x
   Web of Science ®Google Scholar
• Farrell CP, Parker CJ, Phillips JD. Exome sequencing for molecular characterization of non-HFE hereditary hemochromatosis. Blood Cells Mol Dis. 2015;55(2):101–103. doi:10.1016/j.bcmd.2015.04.002
   Web of Science ®Google Scholar
• Lv T, Zhang W, Xu A, et al. Non- HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants. J Med Genet. 2018;55(10):650–660. doi:10.1136/jmedgenet-2018-105348
   Web of Science ®Google Scholar
• Koyama C, Hayashi H, Wakusawa S, et al. Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol. 2005;43(4):740–742. doi:10.1016/j.jhep.2005.06.024
   Web of Science ®Google Scholar
• Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med Genet. 2004;5(1):29. doi:10.1186/1471-2350-5-29
   Google Scholar
• Santiago de Sousa Azulay R, Magalhães M, Tavares MDG, et al. Novel mutation in the Hemojuvelin Gene (HJV) in a patient with juvenile hemochromatosis presenting with insulin-dependent diabetes mellitus, secondary hypothyroidism and hypogonadism. Am J Case Rep. 2020;21:e923108. doi:10.12659/AJCR.923108
   Web of Science ®Google Scholar
• Jacolot S, Le Gac G, Scotet V, et al. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood. 2004;103(7):2835–2840. doi:10.1182/blood-2003-10-3366
   Web of Science ®Google Scholar
• Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33(1):21–22. doi:10.1038/ng1053
   PubMed Web of Science ®Google Scholar
• Roetto A, Daraio F, Porporato P, et al. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood. 2004;103(6):2407–2409. doi:10.1182/blood-2003-10-3390
   Web of Science ®Google Scholar
• Potekhina ES, Lavrov AV, Samokhodskaya LM, et al. Unique genetic profile of hereditary hemochromatosis in Russians: high frequency of C282Y mutation in population, but not in patients. Blood Cells Mol Dis. 2005;35(2):182–188. doi:10.1016/j.bcmd.2005.06.012
   Web of Science ®Google Scholar
• Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, et al. Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5′-UTR of the HAMP gene. Blood. 2004;104(7):2181–2183. doi:10.1182/blood-2004-01-0332
   Web of Science ®Google Scholar
• Glöckner G, Scherer S, Schattevoy R, et al. Large-scale sequencing of two regions in human chromosome 7q22: analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci reveals 17 genes. Genome Res. 1998;8(10):1060–1073. doi:10.1101/gr.8.10.1060
   Web of Science ®Google Scholar
• Rishi G, Crampton EM, Wallace DF, Subramaniam VN, Avila M. In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS One. 2013;8(10):e77267. doi:10.1371/journal.pone.0077267
   Web of Science ®Google Scholar
• Radio FC, Majore S, Binni F, et al. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy. Blood Cells Mol Dis. 2014;52(2–3):83–87. doi:10.1016/j.bcmd.2013.08.003
   Web of Science ®Google Scholar
• Pietrangelo A, Caleffi A, Henrion J, et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology. 2005;128(2):470–479. doi:10.1053/j.gastro.2004.11.057
   Web of Science ®Google Scholar
• Joshi R, Shvartsman M, Morán E, et al. Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3. Mol Genet Genomic Med. 2015;3(3):221–232. doi:10.1002/mgg3.136
   Web of Science ®Google Scholar
• Girelli D, Bozzini C, Roetto A, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology. 2002;122(5):1295–1302. doi:10.1053/gast.2002.32984
   Web of Science ®Google Scholar
• Lee PL, Barton JC. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R. Acta Haematol. 2006;115(1–2):102–105. doi:10.1159/000089474
   Web of Science ®Google Scholar
• Hsiao P-J, Tsai K-B, Shin S-J, et al. A novel mutation of transferrin receptor 2 in a Taiwanese woman with type 3 hemochromatosis. J Hepatol. 2007;47(2):303–306. doi:10.1016/j.jhep.2007.04.014
   Web of Science ®Google Scholar
• Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood. 2001;97(9):2555–2560. doi:10.1182/blood.V97.9.2555
   Web of Science ®Google Scholar
• Pelucchi S, Mariani R, Trombini P, et al. Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. Haematologica. 2009;94(2):276–279. doi:10.3324/haematol.13576
   Web of Science ®Google Scholar
• Pietrangelo A. Ferroportin disease: pathogenesis, diagnosis and treatment. Haematologica. 2017;102(12):1972–1984. doi:10.3324/haematol.2017.170720
   PubMed Web of Science ®Google Scholar
• Sham RL, Phatak PD, Nemeth E, Ganz T. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood. 2009;114(2):493–494. doi:10.1182/blood-2009-04-216226
   PubMed Web of Science ®Google Scholar
• Girelli D, De Domenico I, Bozzini C, et al. Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. J Hepatol. 2008;49(4):664–671. doi:10.1016/j.jhep.2008.05.028
   Web of Science ®Google Scholar
• Majore S, Bonaccorsi Di Patti MC, Valiante M, et al. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Biochim Biophys Acta. 2018;1864(2):464–470. doi:10.1016/j.bbadis.2017.11.006
   Web of Science ®Google Scholar
• Pietrangelo A, Corradini E, Ferrara F, et al. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis. 2006;37:192–196. doi:10.1016/j.bcmd.2006.08.007
   Web of Science ®Google Scholar
• Viprakasit V, Merryweather-Clarke AT, Chinthammitr Y, et al. Molecular diagnosis of the first ferroportin mutation (C326Y) in the far east causing a dominant form of inherited iron overload. Blood. 2004;104(11):3204. doi:10.1182/blood.V104.11.3204.3204
   Web of Science ®Google Scholar
• Preza GC, Ruchala P, Pinon R, et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest. 2011;121(12):4880–4888. doi:10.1172/JCI57693
   PubMed Web of Science ®Google Scholar
• Fernandes A, Preza GC, Phung Y, et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood. 2009;114(2):437–443. doi:10.1182/blood-2008-03-146134
   PubMed Web of Science ®Google Scholar
• Wallace DF, Clark RM, Harley HAJ, Subramaniam VN. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J Hepatol. 2004;40(4):710–713. doi:10.1016/j.jhep.2003.12.008
   Web of Science ®Google Scholar
• Zhang W, Lv T, Huang J, Ou X. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: a case report and a review of the literature. Medicine. 2017;96:e8064.
   Web of Science ®Google Scholar